StreetInsider.com News Articles

Form DEF 14A OSR Health, Inc. For: Aug 07

Thu, 16 Jul 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260716/26780164.html

Form DEF 14A OSR Health, Inc. For: Aug 07

Thu, 16 Jul 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260716/26780164.html

Form PRE 14A OSR Health, Inc. For: Jul 06

Mon, 06 Jul 2026 17:06:00 -0400

si-local-file:///var/storage/secattach/20260706/26736489.html

Form PRE 14A OSR Health, Inc. For: Jul 06

Mon, 06 Jul 2026 17:06:00 -0400

si-local-file:///var/storage/secattach/20260706/26736489.html

CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

Thu, 02 Jul 2026 13:05:00 -0400

The tiered reward structure only has to be at or above the specified price level on the 3, 6, 9, or 12 month observation date. It was previously mentioned that the pricing needed to be sustained over that time period.

NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Emerging Growth Research today issued a flash report on OSR Health, Inc. (Nasdaq:OSRH), formerly OSR Holdings, reaffirming its Buy-Emerging rating and 12-month price target of $10.00.

The flash report highlights OSRH's newly announced Shareholder Loyalty Program, a novel plan to

CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

Thu, 02 Jul 2026 13:05:00 -0400

The flash report highlights OSRH's newly announced Shareholder Loyalty Program, a novel plan to

Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

Thu, 02 Jul 2026 09:00:00 -0400

NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Emerging Growth Research today issued a flash report on OSR Health, Inc. (NASDAQ:OSRH), formerly OSR Holdings, reaffirming its Buy-Emerging rating and 12-month price target of $10.00.

The flash report highlights OSRH's newly announced Shareholder Loyalty Program, a novel plan to reward long-term shareholders with Contingent Value Rights ("CVR") rather than pursuing a reverse stock split. The Company's Board has approved the plan, which remains subject to legal counsel's opinion, with a record date targeted for July 31, 2026.

Key Highlights From the

Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

Thu, 02 Jul 2026 09:00:00 -0400

NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Emerging Growth Research today issued a flash report on OSR Health, Inc. (NASDAQ:OSRH), formerly OSR Holdings, reaffirming its Buy-Emerging rating and 12-month price target of $10.00.
The flash report highlights OSRH's newly announced Shareholder Loyalty Program, a novel plan to reward long-term shareholders with Contingent Value Rights ("CVR") rather than pursuing a reverse stock split. The Company's Board has approved the plan, which remains subject to legal counsel's opinion, with a record date targeted for July 31, 2026.
Key Highlights From the

OSR Health launches CVR program to reward long-term shareholders

Thu, 25 Jun 2026 08:33:15 -0400

OSR Health, Inc. (NASDAQ: OSRH) announced a Shareholder Loyalty Program that would distribute non-transferable Contingent Value Rights (CVRs) to shareholders of record, tentatively as of July 31, 2026, according to a company press release.
Under the program, shareholders would receive one CVR for each share held on the record date. As the stock reaches defined price milestones over the 12 months following the record date, continuous holders would automatically receive additional shares of common stock at no additional cost.
The program is structured in four cumulative tiers. At Tier 1, if the stock reaches $2.00 within three months, holders receive 0.5 additional

OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares

Thu, 25 Jun 2026 08:32:00 -0400

Contingent Value Rights would reward continuous holders with additional shares as the Company meets defined price milestones

BELLEVUE, WA / ACCESS Newswire / June 25, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today announced a Shareholder Loyalty Program designed to reward the investors who hold OSRH stock over the long term. Under the program, the Company plans to distribute non-transferable Contingent Value Rights ("CVRs") to all shareholders of record tentatively as of July 31, 2026. One CVR for every share owned. The Board of Directors has authorized management to proceed with implementation, subject

OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares

Thu, 25 Jun 2026 08:32:00 -0400

Contingent Value Rights would reward continuous holders with additional shares as the Company meets defined price milestones

BELLEVUE, WA / ACCESS Newswire / June 25, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today announced a Shareholder Loyalty Program designed to reward the investors who hold OSRH stock over the long term. Under the program, the Company plans to distribute non-transferable Contingent Value Rights ("CVRs") to all shareholders of record tentatively as of July 31, 2026. One CVR for every share owned. The Board of Directors has authorized management to proceed with implementation, subject

OSR Holdings renames itself OSR Health, keeps OSRH ticker

Mon, 22 Jun 2026 09:06:29 -0400

OSR Holdings, Inc. (NASDAQ: OSRH) has changed its corporate name to OSR Health, Inc., with the change taking effect June 11, 2026, following the filing of a Certificate of Amendment with the Delaware Secretary of State.
The company said the new name more directly reflects its focus on biotechnology, medical technology, life sciences, and wellness markets. The change affects only the legal and brand identity and does not alter stockholder rights, share structure, or other provisions of its governing documents. Shares continue trading on the Nasdaq Capital Market under the ticker symbol "OSRH."
The company's operating subsidiaries, including OSR Holdings Co., Ltd.

OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do

Mon, 22 Jun 2026 09:06:00 -0400

BELLEVUE, WA / ACCESS Newswire / June 22, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced that it has officially changed its corporate name to OSR Health, Inc., a fresh identity that more directly reflects the Company's mission. The change became effective on June 11, 2026 upon the filing of a Certificate of Amendment with the Delaware Secretary of State.
The rebrand is a clearer articulation of the Company's identity as a global health innovation platform operating across biotechnology, medical technology, life sciences, and wellness markets. While "OSR Holdings" described a corporate structure,

OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do

Mon, 22 Jun 2026 09:06:00 -0400

BELLEVUE, WA / ACCESS Newswire / June 22, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced that it has officially changed its corporate name to OSR Health, Inc., a fresh identity that more directly reflects the Company's mission. The change became effective on June 11, 2026 upon the filing of a Certificate of Amendment with the Delaware Secretary of State.
The rebrand is a clearer articulation of the Company's identity as a global health innovation platform operating across biotechnology, medical technology, life sciences, and wellness markets. While "OSR Holdings" described a corporate structure,

Form 8-K OSR Holdings, Inc. For: Jun 05

Thu, 11 Jun 2026 13:35:00 -0400
si-local-file:///var/storage/secattach/20260611/26634870.html

Form 8-K OSR Holdings, Inc. For: Jun 05

Thu, 11 Jun 2026 13:35:00 -0400
si-local-file:///var/storage/secattach/20260611/26634870.html

Form DEFA14A OSR Holdings, Inc.

Thu, 11 Jun 2026 13:33:00 -0400
si-local-file:///var/storage/secattach/20260611/26634854.html

Form DEFA14A OSR Holdings, Inc.

Thu, 11 Jun 2026 13:33:00 -0400
si-local-file:///var/storage/secattach/20260611/26634854.html

CEO Statement to Shareholders

Wed, 03 Jun 2026 12:05:00 -0400

BELLEVUE, WA / ACCESS Newswire / June 3, 2026 / Dear Fellow Shareholders,
As we move through 2026, I would like to provide an update on where OSR Holdings (NASDAQ:OSRH) stands today and how we are approaching the opportunities ahead:
Strategic Focus and Business Development
Over the past year, we have continued to strengthen our position as a biomedical holding company with a growing portfolio of innovative businesses spanning oncology, regenerative medicine, medical devices, and digital health. We are seeing increasing external validation of the technologies and platforms being developed by our subsidiaries.
Vaximm recently executed

CEO Statement to Shareholders

Wed, 03 Jun 2026 12:05:00 -0400

BELLEVUE, WA / ACCESS Newswire / June 3, 2026 / Dear Fellow Shareholders,
As we move through 2026, I would like to provide an update on where OSR Holdings (NASDAQ:OSRH) stands today and how we are approaching the opportunities ahead:
Strategic Focus and Business Development
Over the past year, we have continued to strengthen our position as a biomedical holding company with a growing portfolio of innovative businesses spanning oncology, regenerative medicine, medical devices, and digital health. We are seeing increasing external validation of the technologies and platforms being developed by our subsidiaries.
Vaximm recently executed

Form 8-K OSR Holdings, Inc. For: May 27

Tue, 02 Jun 2026 13:17:00 -0400
si-local-file:///var/storage/secattach/20260602/26590344.html

Form 8-K OSR Holdings, Inc. For: May 27

Tue, 02 Jun 2026 13:17:00 -0400
si-local-file:///var/storage/secattach/20260602/26590344.html

OSR Holdings acquires VXM01 intellectual property for $30 million

Wed, 27 May 2026 09:06:12 -0400

OSR Holdings Inc. (NASDAQ: OSRH) entered into an asset purchase agreement with VAXIMM AG to acquire the complete VXM01 intellectual property portfolio for $30 million, according to a company statement.

The acquisition includes global patents and patent applications, manufacturing know-how, regulatory filings, clinical data, biological materials, and related contracts. Patent protection extends across the United States, Canada, Europe, Japan, China, Korea and other territories through 2038.

The $30 million purchase price becomes payable upon completion of a Phase 2 clinical study of VXM01 in either glioblastoma or pancreatic ductal adenocarcinoma. OSR Holdings may make voluntary partial payments before that milestone.

The transaction follows

OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction

Wed, 27 May 2026 09:06:00 -0400

Transaction Centralizes VXM01 Ownership and Long-Term Royalty Economics at the OSRH Parent Level

BELLEVUE, WA / ACCESS Newswire / May 27, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company focused on innovative therapeutics and healthcare technologies, today announced it has entered into a definitive Asset Purchase Agreement ("APA") with VAXIMM AG ("Vaximm") to acquire the full global intellectual property portfolio and related assets for an aggregate purchase price of $30 million.
The acquisition follows OSRH's previously announced definitive global exclusive license agreement with BCM Europe AG ("BCME") for VXM01, which

OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction

Wed, 27 May 2026 09:06:00 -0400

Transaction Centralizes VXM01 Ownership and Long-Term Royalty Economics at the OSRH Parent Level

BELLEVUE, WA / ACCESS Newswire / May 27, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company focused on innovative therapeutics and healthcare technologies, today announced it has entered into a definitive Asset Purchase Agreement ("APA") with VAXIMM AG ("Vaximm") to acquire the full global intellectual property portfolio and related assets for an aggregate purchase price of $30 million.
The acquisition follows OSRH's previously announced definitive global exclusive license agreement with BCM Europe AG ("BCME") for VXM01, which